-+ 0.00%
-+ 0.00%
-+ 0.00%

Kyung Nam Pharm Corrects Quarterly Report to Add Missing CEO Signature

PUBT·11/16/2026 15:14:12
Kyung Nam Pharm Corrects Quarterly Report to Add Missing CEO Signature
  • Kyung Nam Pharm corrected its third-quarter 2026 report on November 16, 2026, to add the omitted chief executive’s signature.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyung Nam Pharm Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261116002125), on November 16, 2026, and is solely responsible for the information contained therein.